See more : Pci Technology Group Co.,Ltd. (600728.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Hikal Limited (HIKAL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hikal Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Shanghai Dragon Corporation (600630.SS) Income Statement Analysis – Financial Results
- Citigroup Inc. (C) Income Statement Analysis – Financial Results
- EROAD Limited (ERD.AX) Income Statement Analysis – Financial Results
- Kayne Anderson NextGen Energy & Infrastructure, Inc. (KMF) Income Statement Analysis – Financial Results
- Yuexiu Services Group Limited (6626.HK) Income Statement Analysis – Financial Results
Hikal Limited (HIKAL.NS)
About Hikal Limited
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.85B | 20.05B | 19.26B | 17.07B | 15.05B | 15.88B | 12.99B | 10.01B | 9.08B | 8.59B | 8.28B | 6.59B | 7.08B | 5.02B | 5.39B | 5.73B | 4.79B | 4.36B |
| Cost of Revenue | 11.89B | 11.07B | 10.33B | 9.37B | 8.02B | 8.81B | 7.23B | 5.26B | 4.80B | 4.41B | 3.87B | 2.71B | 3.13B | 2.82B | 2.78B | 3.51B | 3.06B | 2.84B |
| Gross Profit | 5.96B | 8.98B | 8.93B | 7.70B | 7.04B | 7.07B | 5.76B | 4.75B | 4.28B | 4.19B | 4.41B | 3.88B | 3.95B | 2.21B | 2.61B | 2.22B | 1.73B | 1.52B |
| Gross Profit Ratio | 33.39% | 44.78% | 46.35% | 45.13% | 46.75% | 44.52% | 44.34% | 47.43% | 47.16% | 48.72% | 53.22% | 58.91% | 55.79% | 43.94% | 48.51% | 38.76% | 36.20% | 34.78% |
| Research & Development | 0.00 | 708.39M | 619.36M | 530.65M | 482.41M | 443.68M | 392.14M | 344.25M | 306.58M | 0.00 | 0.00 | 318.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 614.44M | 570.68M | 426.16M | 225.26M | 210.29M | 156.31M | 116.35M | 145.31M | 121.78M | 119.82M | 111.05M | 84.72M | 1.48B | 425.03M | 416.29M | 530.62M | 545.03M | 520.31M |
| Selling & Marketing | 280.74M | 294.17M | 386.89M | 301.31M | 185.57M | 208.59M | 209.06M | 166.99M | 158.25M | 177.45M | 150.34M | 98.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.46B | 864.85M | 813.05M | 526.57M | 395.86M | 364.90M | 325.41M | 312.30M | 280.03M | 297.27M | 261.39M | 183.41M | 1.48B | 425.03M | 416.29M | 530.62M | 545.03M | 520.31M |
| Other Expenses | 0.00 | 54.10M | 6.25M | 10.13M | 700.00K | 2.87M | 5.16M | 9.21M | 5.91M | 3.80M | 330.71M | 250.00K | 663.78M | 533.14M | 96.66M | 722.54M | 166.61M | 139.25M |
| Operating Expenses | 4.46B | 7.50B | 6.48B | 5.32B | 5.13B | 4.94B | 4.14B | 3.40B | 3.12B | 2.98B | 2.85B | 2.50B | 2.56B | 1.39B | 1.26B | 1.25B | 1.05B | 1.14B |
| Cost & Expenses | 16.33B | 18.57B | 16.81B | 14.68B | 13.14B | 13.75B | 11.37B | 8.66B | 7.92B | 7.39B | 6.72B | 5.21B | 5.68B | 4.21B | 4.03B | 4.76B | 4.11B | 3.98B |
| Interest Income | 16.95M | 19.56M | 17.56M | 26.67M | 25.24M | 19.77M | 30.46M | 25.13M | 12.45M | 11.97M | 9.74M | 11.31M | 9.48M | 0.00 | 0.00 | 0.00 | 9.97M | 20.36M |
| Interest Expense | 561.07M | 481.00M | 261.92M | 319.45M | 461.56M | 476.40M | 456.39M | 503.18M | 454.95M | 504.79M | 517.37M | 478.12M | 663.78M | 437.19M | 380.18M | 329.34M | 166.61M | 146.65M |
| Depreciation & Amortization | 1.18B | 1.09B | 956.69M | 852.45M | 824.62M | 928.79M | 855.93M | 691.41M | 672.76M | 641.90M | 550.36M | 490.74M | 453.50M | 410.75M | 358.18M | 230.36M | 277.25M | 190.28M |
| EBITDA | 2.66B | 2.60B | 3.44B | 3.28B | 2.58B | 2.93B | 2.46B | 1.98B | 1.83B | 1.84B | 2.21B | 1.30B | 1.41B | 1.20B | 1.17B | 899.63M | 976.49M | 549.95M |
| EBITDA Ratio | 14.92% | 13.09% | 17.66% | 19.01% | 18.00% | 18.50% | 18.81% | 20.71% | 18.32% | 20.34% | 25.45% | 26.65% | 26.09% | 23.79% | 21.68% | 16.65% | 20.02% | 12.84% |
| Operating Income | 1.49B | 1.49B | 2.45B | 2.38B | 1.91B | 2.10B | 1.61B | 800.24M | 531.90M | 597.52M | 981.11M | 814.77M | 1.39B | 815.87M | 1.36B | 967.54M | 681.80M | 376.72M |
| Operating Income Ratio | 8.37% | 7.42% | 12.73% | 13.96% | 12.68% | 13.25% | 12.42% | 8.00% | 5.86% | 6.96% | 11.85% | 12.36% | 19.69% | 16.24% | 25.19% | 16.89% | 14.23% | 8.64% |
| Total Other Income/Expenses | -539.15M | -433.82M | -266.84M | -318.03M | -644.76M | -639.06M | -497.94M | -522.09M | -626.31M | -600.15M | -577.37M | -1.06B | -882.27M | 214.37M | -927.42M | -573.18M | -182.61M | -194.54M |
| Income Before Tax | 955.05M | 1.05B | 2.19B | 2.06B | 1.27B | 1.49B | 1.11B | 800.24M | 531.90M | 597.52M | 981.26M | 330.69M | 511.08M | 347.14M | 430.01M | 394.36M | 499.19M | 182.18M |
| Income Before Tax Ratio | 5.35% | 5.26% | 11.35% | 12.09% | 8.41% | 9.39% | 8.59% | 8.00% | 5.86% | 6.96% | 11.86% | 5.02% | 7.22% | 6.91% | 7.98% | 6.88% | 10.42% | 4.18% |
| Income Tax Expense | 259.03M | 269.80M | 580.60M | 732.85M | 421.43M | 460.08M | 342.67M | 161.45M | 119.89M | 193.47M | 342.27M | 78.24M | 50.74M | -23.07M | -69.99M | 32.34M | 39.63M | 37.83M |
| Net Income | 696.02M | 783.90M | 1.60B | 1.33B | 844.35M | 1.03B | 772.27M | 638.79M | 412.01M | 404.05M | 638.99M | 252.45M | 460.34M | 371.71M | 502.80M | 407.76M | 474.37M | 191.07M |
| Net Income Ratio | 3.90% | 3.91% | 8.33% | 7.80% | 5.61% | 6.49% | 5.95% | 6.38% | 4.54% | 4.70% | 7.72% | 3.83% | 6.50% | 7.40% | 9.33% | 7.12% | 9.90% | 4.38% |
| EPS | 5.64 | 6.36 | 13.02 | 10.80 | 6.85 | 8.36 | 6.26 | 5.46 | 3.34 | 3.28 | 5.18 | 2.05 | 3.73 | 3.00 | 4.06 | 3.42 | 4.17 | 1.67 |
| EPS Diluted | 5.64 | 6.36 | 13.02 | 10.80 | 6.85 | 8.36 | 6.26 | 5.46 | 3.34 | 3.28 | 5.18 | 2.05 | 3.73 | 2.94 | 3.91 | 3.29 | 4.02 | 1.67 |
| Weighted Avg Shares Out | 123.40M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 113.10M | 113.10M |
| Weighted Avg Shares Out (Dil) | 123.40M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 123.30M | 128.73M | 123.73M | 119.28M | 123.83M |
Source: https://incomestatements.info
Category: Stock Reports